Investigational Once-Weekly Oral HIV Treatment Regimen of Islatravir and Lenacapavir Maintained Virological Suppression in Adults With HIV Who Switched Antiretroviral Therapy
Merck's LIPFENDRA® is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia
Merck to Present New Data on Daily, Weekly, and Monthly Options Across its HIV Treatment and Prevention Pipeline at AIDS 2026
KEYTRUDA® as Monotherapy Significantly Improved Progression-Free Survival in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient Tumors Compared to Chemotherapy
FDA Approves KEYTRUDA® and KEYTRUDA QLEX , Each With Padcev® , as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Cancer
Merck Announces New Agreement with ADAP Crisis Task Force to Improve Access and Care for People Living with HIV
FDA Approves KEYTRUDA® and KEYTRUDA QLEX , each with Trodelvy® as First-Line Treatment of PD-L1+ Advanced Triple-Negative Breast Cancer
European Commission Approves KEYTRUDA® Plus Padcev® as First PD-1 Inhibitor Plus Antibody-Drug Conjugate Regimen for Adults With Cisplatin-Ineligible Resectable Muscle-Invasive Bladder Cancer
Merck's Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to Severely Active Ulcerative Colitis
U.S. FDA Approves an Additional Indication for CAPVAXIVE® in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal Disease
Study Reveals Dog Owners and Veterinarians See Challenges in Treating Allergic Skin Disease, Highlighting a Need for a Targeted Rapid Onset Treatment for Dogs of All Ages
FDA Approves KEYTRUDA® and KEYTRUDA QLEX , Each With WELIREG® , for Adjuvant Treatment of Certain Patients With Clear Cell Renal Cell Carcinoma
Precious Metals & Critical Minerals Virtual Investor Conference Presentations Now Available for On-Demand Viewing
Precious Metals & Critical Minerals Virtual Investor Conference Presentations Now Available for On-Demand Viewing
Precious Metals & Critical Minerals Virtual Investor Conference Presentations Now Available for On-Demand Viewing
